Related Experiment Video
Updated: Jun 1, 2026
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Directly acting antivirals against hepatitis C virus
Vincent Soriano1, Eugenia Vispo, Eva Poveda
1Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragonet.es
The Journal of Antimicrobial Chemotherapy
|June 10, 2011
Summary
Directly acting antivirals (DAA) offer a cure for chronic hepatitis C virus (HCV) infection, a significant advancement over older treatments. Personalized therapy selection is crucial for maximizing success and preventing drug resistance in HCV patients.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Chronic hepatitis C virus (HCV) infection affects 180 million people globally.
- Current treatments like peginterferon-alfa plus ribavirin have limited efficacy and significant side effects.
- Hepatitis C is unique as the only curable chronic viral human disease.
Purpose of the Study:
- To review the advent of directly acting antivirals (DAA) for chronic hepatitis C treatment.
- To highlight the potential of new therapeutic strategies including DAAs, novel interferons, and host-targeting agents.
- To discuss the implications for personalized medicine and the future of HCV management.
Main Methods:
- Review of clinical development of DAAs targeting HCV NS3 protease, NS5B polymerase, and NS5A replication complex.
- Assessment of emerging therapies like interferon-lambda and host protein inhibitors (e.g., alisporivir).
- Analysis of treatment outcomes and resistance patterns associated with new HCV therapies.
Main Results:
- DAAs represent a breakthrough in HCV treatment, offering higher cure rates.
- New therapeutic agents promise improved safety and efficacy profiles.
- Individualized treatment strategies based on viral and host factors are emerging.
Conclusions:
- DAA approval marks a new era in hepatitis C therapeutics, comparable to HIV treatment advancements.
- Personalized HCV therapy is essential to optimize outcomes and minimize drug resistance.
- The complexity of treatment may necessitate specialized HCV clinicians.
More Related Videos
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...